Article and paper data contributed by Molecular
spec sheet12 rows
Androsterone (3α-hydroxy-5α-androstan-17-one) is an endogenous androstane neurosteroid (a steroid synthesized or acting within the nervous system) and a peripheral metabolite of testosterone and dehydroepiandrosterone. Like its pregnane counterpart allopregnanolone, it acts as a positive allosteric modulator (an agent that enhances a receptor's response to its natural transmitter) of the GABA-A receptor (the brain's principal inhibitory ion channel), producing barbiturate-like potentiation of inhibitory neurotransmission. In rodent studies it raises seizure threshold across multiple models and is regarded as an endogenous modulator of neuronal excitability; because native androsterone is rapidly conjugated and orally poorly available, a prodrug (an inactive precursor that converts to the active drug in the body) has been investigated for epilepsy.
- Weak androgen; sold as a prohormone toward DHT
- GABA-A neurosteroid; mild calming
- Natural testosterone/DHEA metabolite
- Studied for anticonvulsant activity in animals
- Positive allosteric modulation of GABA-A receptors that enhances inhibitory neurotransmission
- Dose-dependent anticonvulsant activity across multiple rodent seizure models (6-Hz, pentylenetetrazol, pilocarpine, maximal electroshock)
- Barbiturate-like efficacy profile that can protect where benzodiazepine-site modulators are limited
- Potentiation of tonic inhibition via extrasynaptic delta-subunit GABA-A receptors
- Serves as an endogenous buffer of neuronal excitability and seizure susceptibility
- Its prodrug and unnatural-enantiomer forms offer routes to improved potency and drug-like exposure
- Androgenic effects (as with any prohormone)
- Possible testosterone suppression with sustained use
- Can shift cholesterol/lipids
- Sedation and central nervous system depression at higher exposures, consistent with strong GABAergic potentiation
- Motor impairment and reduced coordination in animal studies at anticonvulsant doses
- Potential tolerance and withdrawal concerns common to GABA-A modulators
- Possible influence on circadian and neuroendocrine timing given phase-dependent effects
Overview
The androstane analog of allopregnanolone's GABA-A action; an endogenous, barbiturate-like anticonvulsant neurosteroid derived from testosterone and DHEA metabolism.
- Androsterone was the first androgen ever isolated, extracted by Adolf Butenandt in 1931 from a very large batch of male urine; his steroid work contributed to the 1939 Nobel Prize in Chemistry.
- Its mirror-image (unnatural enantiomer, ent-androsterone) is equally or more potent as an anticonvulsant than the natural molecule, a clue that its GABA-A binding is not a classical chiral lock-and-key fit.
- The 3α-hydroxyl group is decisive: the 3β-epimer epiandrosterone is essentially inactive at the GABA-A receptor despite differing only in the orientation of a single hydroxyl.
- At high concentrations androsterone can open the GABA-A channel directly without GABA present, a barbiturate-like behavior that distinguishes it from benzodiazepine-site drugs.
Mechanism
Androsterone carries the 3α-hydroxyl configuration that defines -A-active neurosteroids; this stereochemistry at carbon 3 is essential, as the 3β-epimer (epiandrosterone) is inactive at the receptor. It binds transmembrane sites on the GABA-A receptor distinct from the benzodiazepine and orthosteric GABA sites, prolonging channel open time and increasing chloride (Cl-) conductance.
At low concentrations it behaves as a positive modulator that potentiates -evoked currents, and at higher concentrations it can directly gate the channel in the absence of GABA, a barbiturate-like profile that contributes to its anticonvulsant efficacy. Activity extends to extrasynaptic delta-subunit-containing GABA-A receptors that mediate tonic inhibition (a persistent background inhibitory current), a substrate shared with allopregnanolone.
Biosynthetically, androsterone is a 5α-reduced, 3α-reduced downstream of testosterone and of dehydroepiandrosterone; sequential action of 5α-reductase and 3α-hydroxysteroid dehydrogenase converts dihydrotestosterone and related precursors toward androsterone, and it is also a node in the alternative "backdoor" androgen pathway operating through 5α-reduced intermediates. Circulating androsterone exists largely as inactive sulfate and glucuronide conjugates; the free steroid is the neuroactive species.
As a modest it retains weak androgenic character, but its central relevance is overwhelmingly rather than hormonal. A notable and mechanistically informative feature is that the unnatural (ent-androsterone, the mirror-image molecule) is equally or more potent as an anticonvulsant than the natural form, arguing that the binding interaction is not strictly governed by classical chiral lock-and-key recognition.
receptor fingerprint
DHT conversion (5-alpha pathway)precursor / substrate
-A receptorpositive allosteric modulator
Extrasynaptic delta-subunit -A receptorsPotentiation of tonic inhibitory current
-A receptor ()Positive allosteric modulation (barbiturate-like)
weak agonist
Extrasynaptic delta-subunit -A receptorPositive allosteric potentiation of tonic current
-A receptor channelDirect channel gating in the absence of GABA at higher concentrations
5-alpha-reductase / 3-alpha-HSD (AKR1C) axisMetabolic interconversion node
Safetyrisks and cautions, not medical advice
Used as a prohormone it carries the usual androgen cautions; it can shift hormone balance, affect cholesterol, and suppress the body's own testosterone with sustained use, and being androgenic it is not for anyone who should avoid androgens. Human data are limited. Not medical advice.
History
Androsterone holds a foundational place in steroid endocrinology; it was the first androgen ever isolated, obtained in 1931 by Adolf Butenandt from a large volume of male urine, work in the sterol and sex-hormone field for which he shared the 1939 Nobel Prize in Chemistry. For decades it was studied chiefly as an androgen excretion metabolite and a marker of adrenal and gonadal steroid output. Interest in its neuroactive profile followed the broader recognition in the 1980s and 1990s that 3α-hydroxy ring-A-reduced steroids modulate the GABA-A receptor.
Dedicated anticonvulsant characterization arrived in 2005, when Kaminski and colleagues reported dose-dependent seizure protection by androsterone and etiocholanolone across several rodent models, framing them as endogenous modulators of seizure susceptibility. Subsequent Polish pharmacology groups (Mróz, Tutka) and a 2014 enantioselectivity study extended the work, and the poor pharmacokinetics of the native molecule motivated prodrug approaches aimed at epilepsy therapy.
Reputation
Within neuropharmacology androsterone is respected as a genuine endogenous GABA-A modulator and a mechanistically instructive "androstane analog" of allopregnanolone, valued more as a research probe and drug-development lead than as an established therapeutic. In the supplement and bodybuilding market the same molecule is sold as a prohormone marketed for androgenic and anabolic effects, a context largely separate from and not validated for its neurosteroid actions. Its central-nervous-system reputation rests on consistent preclinical anticonvulsant data rather than controlled human trials, so it is best described as a promising but clinically unproven neuroactive steroid.
Subjective profileweighing the evidence above
Best treated as a prohormone, with the whole prohormone bill attached: androgenic effects, cholesterol shifts and suppression of your own testosterone with sustained use. The GABA-A calming angle is real but mild, and it is nowhere near a good enough reason to run an androgen.
Resources
Don't even think about it.
Research
- 1998first citedNeurosteroid action at the GABAA receptor in fetal rat forebrain.
- 2010most active year3 papers
- 2025most recentNew directions in neurosteroid therapeutics in neuropsychiatry
- 1.Interaction of androsterone and progesterone with inhibitory ligand-gated ion channels: a patch clamp study
- 2.Classic and current concepts in adrenal steroidogenesis: a reappraisal
- 3.Neurosteroids and Seizure Activity
- 4.Anticonvulsant activity of androsterone and etiocholanolone.
- 5.Anticonvulsant potencies of the enantiomers of the neurosteroids androsterone and etiocholanolone exceed those of the natural forms.
- 6.Effects of androsterone on convulsions in various seizure models in mice.
- 7.Effects of androsterone on the protective action of various antiepileptic drugs against maximal electroshock-induced seizures in mice.
- 8.Effect of Androsterone after Pilocarpine-induced Status Epilepticus in Mice.
- 9.Diurnal variation in the proconvulsant effect of 3-mercaptopropionic acid and the anticonvulsant effect of androsterone in the Syrian hamster.
- 10.The neurosteroid dehydroepiandrosterone (DHEA) and its metabolites alter 5-HT neuronal activity via modulation of GABAA receptors.
- 11.Effects of valproate and carbamazepine monotherapy on neuroactive steroids, their precursors and metabolites in adult men with epilepsy.
- 12.The activities of 5α-reductase and 17,20-lyase determine the direction through androgen synthesis pathways in patients with 21-hydroxylase deficiency.
33 listed here; entry last updated August 2026
Reviews
My notesprivate to this device
FAQ
Is androsterone a strong steroid?
No; it is a weak androgen. Its interest is partly as a mild prohormone and partly as a calming GABA-A neurosteroid.
Why is it described as a neurosteroid?
Its 3-alpha-reduced structure lets it positively modulate GABA-A receptors, like allopregnanolone, giving mild calming and anticonvulsant effects.
Any cautions?
It is androgenic, so it carries prohormone risks (hormone balance, lipids, natural testosterone suppression) and is not for those avoiding androgens.
Is androsterone the same kind of neurosteroid as allopregnanolone?
Mechanistically yes; both are 3α-hydroxy ring-A-reduced steroids that act as positive allosteric modulators of the GABA-A receptor. Androsterone is the androstane (androgen-derived) counterpart, whereas allopregnanolone is the pregnane (progesterone-derived) counterpart, but they engage the same receptor sites and both enhance inhibitory neurotransmission.
Does androsterone have androgenic (hormonal) effects?
It is a weak androgen and a downstream metabolite of testosterone and DHEA, so it retains modest androgen-receptor activity. In the brain, however, its dominant action is GABAergic modulation rather than hormonal signaling, and the two roles are largely independent.
Why is a prodrug being developed instead of using androsterone itself?
Native androsterone is rapidly conjugated (glucuronidated and sulfated) and has poor oral bioavailability, so it is difficult to achieve sustained brain exposure. A prodrug is designed to survive absorption and release the active steroid centrally, which is the strategy being explored for epilepsy.
Has androsterone been proven to treat seizures in people?
No. The anticonvulsant evidence is preclinical, drawn from multiple rodent seizure models. It is a validated research lead and drug-development starting point, not an approved or clinically proven anticonvulsant.
Is the androsterone sold as a bodybuilding supplement the same molecule?
Yes, it is chemically the same steroid, marketed as a prohormone for androgenic and anabolic purposes. That use is separate from its neurosteroid actions and does not validate any central-nervous-system benefit.
Limitations of the evidence
- Limited human data
- Human safety and long-term profile are not established by controlled clinical trials
Adverse effects
- Androgenic effects (as with any prohormone)
- Possible testosterone suppression with sustained use
- Can shift cholesterol/lipids
- Sedation and central nervous system depression at higher exposures, consistent with strong GABAergic potentiation
- Motor impairment and reduced coordination in animal studies at anticonvulsant doses
- Potential tolerance and withdrawal concerns common to GABA-A modulators
- Possible influence on circadian and neuroendocrine timing given phase-dependent effects
Notes and cautions
- Weak androgenic activity as an androgen-receptor ligand, relevant to supplement (prohormone) use